New radiotherapy method for breast cancer shows promise in reducing side effects
NCT ID NCT07407192
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at side effects from a special radiotherapy technique called simultaneous integrated boost (SIB) given after breast-conserving surgery for breast cancer. 93 women were followed to see how well they tolerated the treatment. The goal was to compare side effects with published data to improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy
What this could lead to
If successful, this could help doctors choose safer radiotherapy methods for breast cancer patients after lumpectomy.
What could go wrong
This is a small, completed study that only measures side effects, not whether the treatment works better than standard care. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia